Literature DB >> 15322187

Targeted deletion of protein kinase C lambda reveals a distribution of functions between the two atypical protein kinase C isoforms.

Rachel S Soloff1, Carol Katayama, Meei Yun Lin, James R Feramisco, Stephen M Hedrick.   

Abstract

Protein kinase C lambda (PKClambda) is an atypical member of the PKC family of serine/threonine kinases with high similarity to the other atypical family member, PKCzeta. This similarity has made it difficult to determine specific roles for the individual atypical isoforms. Both PKClambda and PKCzeta have been implicated in the signal transduction, initiated by mediators of innate immunity, that culminates in the activation of MAPKs and NF-kappaB. In addition, work from invertebrates shows that atypical PKC molecules play a role in embryo development and cell polarity. To determine the unique functions of PKClambda, mice deficient for PKClambda were generated by gene targeting. The ablation of PKClambda results in abnormalities early in gestation with lethality occurring by embryonic day 9. The role of PKClambda in cytokine-mediated cellular activation was studied by making mouse chimeras from PKClambda-deficient embryonic stem cells and C57BL/6 or Rag2-deficient blastocysts. Cell lines derived from these chimeric animals were then used to dissect the role of PKClambda in cytokine responses. Although the mutant cells exhibited alterations in actin stress fibers and focal adhesions, no other phenotypic differences were noted. Contrary to experiments using dominant interfering forms of PKClambda, mutant cells responded normally to TNF, serum, epidermal growth factor, IL-1, and LPS. In addition, no abnormalities were found in T cell development or T cell activation. These data establish that, in vertebrates, the two disparate functions of atypical PKC molecules have been segregated such that PKCzeta mediates signal transduction of the innate immune system and PKClambda is essential for early embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322187     DOI: 10.4049/jimmunol.173.5.3250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanisms.

Authors:  Jane Oliaro; Vanessa Van Ham; Faruk Sacirbegovic; Anupama Pasam; Ze'ev Bomzon; Kim Pham; Mandy J Ludford-Menting; Nigel J Waterhouse; Michael Bots; Edwin D Hawkins; Sally V Watt; Leonie A Cluse; Chris J P Clarke; David J Izon; John T Chang; Natalie Thompson; Min Gu; Ricky W Johnstone; Mark J Smyth; Patrick O Humbert; Steven L Reiner; Sarah M Russell
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Analysis of aPKClambda and aPKCzeta reveals multiple and redundant functions during vertebrate retinogenesis.

Authors:  Shuang Cui; Cécile Otten; Stefan Rohr; Salim Abdelilah-Seyfried; Brian A Link
Journal:  Mol Cell Neurosci       Date:  2007-01-12       Impact factor: 4.314

3.  Protein kinase C isozymes as therapeutic targets for treatment of human cancers.

Authors:  Alan P Fields; Nicole R Murray
Journal:  Adv Enzyme Regul       Date:  2008-03-18

4.  Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Authors:  Elena M Rodriguez; Elizabeth E Dunham; G Steven Martin
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

5.  Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome.

Authors:  Tobias B Huber; Björn Hartleben; Kirstin Winkelmann; Lisa Schneider; Jan U Becker; Michael Leitges; Gerd Walz; Hermann Haller; Mario Schiffer
Journal:  J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 10.121

6.  The carboxyl-terminal domain of atypical protein kinase Czeta binds to ceramide and regulates junction formation in epithelial cells.

Authors:  Guanghu Wang; Kannan Krishnamurthy; Nagavedi S Umapathy; Alexander D Verin; Erhard Bieberich
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

7.  Atypical protein kinase C expression in phrenic motor neurons of the rat.

Authors:  C H Guenther; S Vinit; J A Windelborn; M Behan; G S Mitchell
Journal:  Neuroscience       Date:  2010-05-15       Impact factor: 3.590

Review 8.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

9.  Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι.

Authors:  Kirstin Worthmann; Michael Leitges; Beina Teng; Marcello Sestu; Irini Tossidou; Thomas Samson; Hermann Haller; Tobias B Huber; Mario Schiffer
Journal:  Am J Pathol       Date:  2013-10-03       Impact factor: 4.307

10.  Atypical protein kinase Cλ is critical for growth factor receptor-induced dorsal ruffle turnover and cell migration.

Authors:  Bowen Xing; Limin Wang; Dagang Guo; Jianyun Huang; Cedric Espenel; Geri Kreitzer; J Jillian Zhang; Lin Guo; Xin-Yun Huang
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.